Valuation: BOIRON

Market Cap 48Cr 55Cr 44Cr 41Cr 78Cr 5.19TCr 79Cr 530.51Cr 205.55Cr 2.55TCr 204.93Cr 200.49Cr 8.86TCr P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 43Cr 49Cr 40Cr 37Cr 70Cr 4.67TCr 71Cr 477.53Cr 185.02Cr 2.29TCr 184.46Cr 180.47Cr 7.98TCr EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day+0.72%
1 week-0.71%
Current month+0.36%
1 month-3.14%
3 months-0.71%
6 months-7.64%
Current year-8.25%
1 week 27.5
Extreme 27.5
28.2
1 month 27.1
Extreme 27.1
29
Current year 24.35
Extreme 24.35
30.95
1 year 20.85
Extreme 20.85
32.25
3 years 20.85
Extreme 20.85
56.5
5 years 20.85
Extreme 20.85
56.5
10 years 20.85
Extreme 20.85
92.91
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2025
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 65 01/07/2011
Director/Board Member 54 10/03/2010
Director/Board Member 51 23/05/2013
Date Insider Type Main position Quantity % Market Cap.
29/23/29Sell

Director

1,98,664 1.1323%
29/23/29Sell

Chairman

4,748 0.0271%
29/23/29Sell 2,978 0.0170%
Change 5-day change 1-year change 3-year change Capi.($)
+0.72%-0.71%+25.23%-29.62% 55Cr
+1.27%+0.71%-13.99%-8.59% 1.26TCr
+0.61%+1.31%-35.65%-59.61% 469.32Cr
+1.50%+3.86%-10.98%-13.86% 435.27Cr
+2.33%-1.29%+8.17%-40.25% 377.45Cr
+2.98%+1.05%+13.17%-14.61% 377.22Cr
+1.22%-16.35%-14.63%-22.66% 304.68Cr
+2.80%-1.52%-13.38%-6.27% 299.04Cr
+3.15%-0.20%-7.61%-26.86% 233.75Cr
+3.04%+0.91%-11.05%+24.35% 165.53Cr
Average +1.96%+0.37%-6.07%-19.80% 397.66Cr
Weighted average by Cap. +1.77%+0.95%-10.50%-19.66%

Financials

2024 2025
Net sales 49Cr 56Cr 45Cr 42Cr 79Cr 5.28TCr 80Cr 539.77Cr 209.13Cr 2.59TCr 208.5Cr 203.99Cr 9.02TCr 50Cr 57Cr 46Cr 43Cr 81Cr 5.43TCr 83Cr 554.77Cr 214.94Cr 2.66TCr 214.29Cr 209.66Cr 9.27TCr
Net income 1.13Cr 1.29Cr 1.04Cr 97.23L 1.83Cr 122.75Cr 1.87Cr 13Cr 4.86Cr 60Cr 4.85Cr 4.74Cr 209.7Cr 3.26Cr 3.72Cr 3Cr 2.8Cr 5.28Cr 353.47Cr 5.39Cr 36Cr 14Cr 173.5Cr 14Cr 14Cr 603.84Cr
Net Debt -4.97Cr -5.66Cr -4.58Cr -4.27Cr -8.05Cr -538.58Cr -8.21Cr -55Cr -21Cr -264.37Cr -21Cr -21Cr -920.06Cr -4.79Cr -5.45Cr -4.4Cr -4.1Cr -7.74Cr -518.19Cr -7.9Cr -53Cr -21Cr -254.36Cr -20Cr -20Cr -885.23Cr
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499
Date Price Change Volume
02/26/02 27.80 +0.72% 135
01/26/01 €27.60 -0.36% 772
30/26/30 €27.70 -1.07% 930
29/26/29 €28.00 -0.71% 529
26/26/26 €28.20 +0.71% 994

Annual profits - Rate of surprise